1. Home
  2. CARA vs XIN Comparison

CARA vs XIN Comparison

Compare CARA & XIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CARA
  • XIN
  • Stock Information
  • Founded
  • CARA 2004
  • XIN 1997
  • Country
  • CARA United States
  • XIN China
  • Employees
  • CARA N/A
  • XIN N/A
  • Industry
  • CARA Biotechnology: Pharmaceutical Preparations
  • XIN Homebuilding
  • Sector
  • CARA Health Care
  • XIN Consumer Discretionary
  • Exchange
  • CARA Nasdaq
  • XIN Nasdaq
  • Market Cap
  • CARA 16.7M
  • XIN 15.9M
  • IPO Year
  • CARA 2014
  • XIN N/A
  • Fundamental
  • Price
  • CARA $4.65
  • XIN $2.82
  • Analyst Decision
  • CARA Hold
  • XIN
  • Analyst Count
  • CARA 3
  • XIN 0
  • Target Price
  • CARA $12.00
  • XIN N/A
  • AVG Volume (30 Days)
  • CARA 331.3K
  • XIN 21.5K
  • Earning Date
  • CARA 03-03-2025
  • XIN 01-01-0001
  • Dividend Yield
  • CARA N/A
  • XIN N/A
  • EPS Growth
  • CARA N/A
  • XIN N/A
  • EPS
  • CARA N/A
  • XIN N/A
  • Revenue
  • CARA $8,686,000.00
  • XIN $667,143,185.00
  • Revenue This Year
  • CARA N/A
  • XIN N/A
  • Revenue Next Year
  • CARA N/A
  • XIN N/A
  • P/E Ratio
  • CARA N/A
  • XIN $0.32
  • Revenue Growth
  • CARA N/A
  • XIN N/A
  • 52 Week Low
  • CARA $2.71
  • XIN $2.24
  • 52 Week High
  • CARA $13.80
  • XIN $7.05
  • Technical
  • Relative Strength Index (RSI)
  • CARA 52.14
  • XIN 50.53
  • Support Level
  • CARA $4.32
  • XIN $2.53
  • Resistance Level
  • CARA $4.92
  • XIN $2.86
  • Average True Range (ATR)
  • CARA 0.66
  • XIN 0.24
  • MACD
  • CARA -0.10
  • XIN 0.04
  • Stochastic Oscillator
  • CARA 28.75
  • XIN 69.35

About CARA Cara Therapeutics Inc.

Cara Therapeutics Inc is a development-stage biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.

About XIN Xinyuan Real Estate Co Ltd

Xinyuan Real Estate Co Ltd operates as a real estate developer and property manager in China. It focuses on developing residential projects, which typically consist of multiple residential buildings that include multi-layer apartment buildings, and others. Its several projects include auxiliary services and amenities such as retail outlets, leisure and health facilities, kindergartens, and schools. It aims to provide comfortable and convenient real estate-related products and services to middle-class consumers.

Share on Social Networks: